Catalogue


Bad pharma : how drug companies mislead doctors and harm patients /
Ben Goldacre.
edition
Paperback edition.
imprint
[Toronto] : Signal, McClelland & Stewart, 2014.
description
xviii, 456 pages : illustrations, charts ; 21 cm
ISBN
9780771036309
format(s)
Book
Holdings
More Details
imprint
[Toronto] : Signal, McClelland & Stewart, 2014.
isbn
9780771036309
general note
"This paperback edition published 2014."--Title page verso.
catalogue key
10270277
 
Includes bibliographical references and index.
A Look Inside
Reviews
Review Quotes
Praise for Bad Pharma "Goldacre uncovers a cesspool of corrupt practices designed to sell useless or dangerous drugs to an unsuspecting public. . . . A smart, infuriating diagnosis of the rotten heart of the medical-industrial complex." - Publishers Weekly "A scathing critique of the modus operandi of drug research. . . . Bad Pharma could very well be the book that initiates a game-changing global rethink of what we expect from medicine." - Globe and Mail
To find out how to look for other reviews, please see our guides to finding book reviews in the Sciences or Social Sciences and Humanities.
Summaries
Main Description
"Bad Science" hilariously exposed the tricks that quacks and journalists use to distort science, becoming an international bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. We like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by pharmaceutical industry. We like to imagine that regulators let only effective drugs onto the market, when in reality they approve hopeless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been protected from public scrutiny because theyre too complex to capture in a sound bite. Ben Goldacre, however, shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct on a global scale affects us. With Goldacres characteristic flair and a forensic attention to detail, "Bad Pharma" reveals a shockingly broken system and calls for something to be done. This is the pharmaceutical industry as it has never been seen before.
Main Description
Bad Science hilariously exposed the tricks that quacks and journalists use to distort science, becoming an international bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. We like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by pharmaceutical industry. We like to imagine that regulators let only effective drugs onto the market, when in reality they approve hopeless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been protected from public scrutiny because they're too complex to capture in a sound bite. Ben Goldacre, however, shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct on a global scale affects us. With Goldacre's characteristic flair and a forensic attention to detail, Bad Pharma reveals a shockingly broken system and calls for something to be done. This is the pharmaceutical industry as it has never been seen before.

This information is provided by a service that aggregates data from review sources and other sources that are often consulted by libraries, and readers. The University does not edit this information and merely includes it as a convenience for users. It does not warrant that reviews are accurate. As with any review users should approach reviews critically and where deemed necessary should consult multiple review sources. Any concerns or questions about particular reviews should be directed to the reviewer and/or publisher.

  link to old catalogue

Report a problem